1. Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes 
James M. Foran, MD, FRCPC, Jamile M. Shammo, MD, FASCP, FACP 
The American Journal of Medicine 
Volume 125, Issue 7, Pages S6-S13 (July 2012)
DOI: /j.amjmed
Copyright © 2012 Elsevier Inc. Terms and Conditions

2. Figure 1
Morphologic features of dysgranulopoiesis can be seen in either a blood or bone marrow aspirate smear: nuclear hyposegmentation, so-called “pseudo-Pelger-Huet” or “Pelgeroid” anomaly.
(Reprinted with permission from Hematol Oncol Clin North Am.31)
The American Journal of Medicine  , S6-S13DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions

3. Figure 2
Flow-chart: diagnosis workup and referral of patients with myelodysplastic syndromes (MDS). AI = autoimmune; BM = bone marrow; CBC = complete blood count; EPO = erythropoietin; GI = gastrointestinal; ITP = idiopathic thrombocytopenic purpura; NCCN = National Comprehensive Cancer Network; RBC = red blood cell.
The American Journal of Medicine  , S6-S13DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions